Search Login Register

Pathologic Neovascularization Summary

Description: A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.

Also Known As: Neovascularization, Pathologic; Angiogenesis, Pathological; Neovascularization, Pathological; Pathologic Angiogenesis; Pathological Angiogenesis Show All >>

Networked: 806 relevant articles (12 outcomes, 50 trials/studies) for this Disease

Key Drugs and Agents for Pathologic Neovascularization

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 4 outcomes 14 studies in 362 results : IBA
  2. Retinaldehyde (Retinal) : 2 outcomes 7 studies in 59 results : IBA
  3. glucuronyl glucosamine glycan sulfate (Vessel) : 2 outcomes 1 study in 27 results : IBA
  4. Angiopoietins : 1 outcome 2 studies in 6 results : IBA
  5. Sirolimus (Rapamycin) : 1 outcome 1 study in 3 results : FDA 2
  6. candesartan : 1 outcome in 2 results : IBA
  7. p38 Mitogen-Activated Protein Kinases : 1 outcome in 1 result : IBA
  8. Epidermal Growth Factor Receptor (EGF Receptor) : 1 outcome in 1 result : IBA
  9. Flavonoids : 1 outcome in 1 result : IBA
  10. Chalcone (Benzalacetophenone) : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Pathologic Neovascularization

  1. Neoplasms (Cancer)
  2. Ischemia
  3. Diabetic Retinopathy (Retinopathy, Diabetic)
  4. Retinopathy of Prematurity (Retrolental Fibroplasia)
  5. Kaposi Sarcoma (Kaposi's Sarcoma)
Show All >>

Key Therapies for Pathologic Neovascularization

Efficacy Chart >>
  1. Therapeutics : 1 study in 3 results
  2. Lasers (Laser) : 8 results
  3. Intravitreal Injections : 5 results
  4. Heterologous Transplantation (Xenotransplantation) : 2 results
  5. Light Coagulation : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.